Cite
HARVARD Citation
Fujii, S. et al. (2022). RAF1–MEK/ERK pathway‐dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation. Journal of pathology. 256 (1), pp. 119-133. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fujii, S. et al. (2022). RAF1–MEK/ERK pathway‐dependent ARL4C expression promotes ameloblastoma cell proliferation and osteoclast formation. Journal of pathology. 256 (1), pp. 119-133. [Online].